Latest Markets Business BEEPS Earnings Personal Finance

Tata Steel Q3 Results: Surprise Profit Of Rs 327 Crore, Beats Estimates

The steel maker's profit beat the Rs 300-crore-loss estimate of analysts polled by Bloomberg.

Mihika Barve

Tata Steel Ltd. reported a fall in the net profit for the quarter ended Dec. 31, according to the financial results declared by the steelmaker on Monday (Photo source: Freepik)

Tata Steel Ltd. reported a fall in the net profit for the quarter ended Dec. 31, according to the financial results declared by the steelmaker on Monday.

The steel manufacturer's profit fell 36% in the third quarter to Rs 327 crore. In the year-ago period, Tata Steel had posted a profit of Rs 513 crore. The company's profit in the quarter under review beat the Rs 300-crore-loss estimate of analysts polled by Bloomberg.

Tata Steel Q3 FY25 Highlights (Consolidated, YoY)

  • Revenue down 3% to Rs 53,648 crore versus Rs 55,312 crore (Bloomberg Estimate: Rs 52,438 crore)

  • Ebitda down 5.7% to Rs 5,903 crore versus Rs 6,264 crore (Bloomberg Estimate: Rs 4,741.90 crore)

  • Margins at 11% vs 11.3% (Bloomberg Estimate: 9%)

  • Net profit down 36.4% to Rs 327 crore versus Rs 513 crore (Bloomberg Estimate: Rs 300 crore loss)

(This is a developing story)

Also Read: Q3 Results Updates: Tata Steel Posts Surprise Profit, IOCL Profit Surges, Coal India Sees Decline

Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.
WRITTEN BY
Mihika Barve
Mihika Barve is a NISM Certified Research Analyst at NDTV Profit actively t... more
GET REGULAR UPDATES
Add us to your Preferences
Set as your preferred source on Google
Beeps Img

AstraZeneca To Develop Gene-Editing Therapy Using Nobel Prize-Winning Tech

  • chevron-double-right AstraZeneca signed a $555 million deal with Algen Biotechnologies for gene-editing therapies
  • chevron-double-right Algen uses AI and gene-editing tools to develop treatments, focusing on immune system diseases
  • chevron-double-right Few AI-developed drugs have reached final trials, and none have yet been approved
More Beeps chevron-right

RECOMMENDED FOR YOU

Tata Steel Receives Rs 2,410.89 Crore Demand From Odisha Authorities Over Chrome Ore Dispatch Shortfall
timelogo Oct 04, 2025
Stocks To Watch Today: Tata Steel, Dalmia Bharat, Lupin, Max Financial And More
timelogo Sep 25, 2025
Stay 'Neutral' On Tata Steel Shares Maintains Motilal Oswal Citing Growth Plans, Strong Outlook
timelogo Sep 23, 2025
Metals, Mining Q1 Results Review— Inline Show; Tata Steel, JSW Steel, NMDC Among Systematix' Top Picks
timelogo Aug 27, 2025

POPULAR

1
Bihar Elections 2025 Date Announcement LIVE: Voting In Two Phases From Nov 6, Results On Nov 14
2
Bihar Elections 2025 Dates: Voting From Nov 6 In Two Phases, Results On Nov 14
3
Tata Capital IPO GMP: What Grey Market Signals As Biggest IPO Of 2025 Opens For Subscription Today
4
Navi Mumbai Airport To See First Passenger Flight Take Off In December
5
Trent Q2 Update: Revenue Rises 17%; Shares Decline
Google Badge